Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study

The development of new biologic and targeted synthetic DMARDs can lead to good disease control. The aim of the present study was to assess the rate of remission and low disease activity, and the improvement of pain and function, in psoriatic arthritis (PsA) patients treated with new anti-IL-12/23 an...

Full description

Saved in:
Bibliographic Details
Main Authors: F.M. Perrotta (Author), A. Delle Sedie (Author), S. Scriffignano (Author), P. Volpe (Author), E. Cordisco (Author), N. Milano (Author), M. Gabini (Author), E. Lubrano (Author)
Format: Book
Published: PAGEPress Publications, 2020-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available